NEVRO CORP's ticker is and the CUSIP is 64157FAA1. A total of 13 filers reported holding NEVRO CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $53,950,000 | +22.9% | 29,934,000 | +2.2% | 0.14% | +1.4% |
| Q3 2020 | $43,883,000 | +62.5% | 29,284,000 | +47.3% | 0.14% | +48.9% |
| Q2 2020 | $27,002,000 | +10.6% | 19,880,000 | -3.2% | 0.09% | -13.0% |
| Q1 2020 | $24,422,000 | -12.3% | 20,540,000 | +0.2% | 0.11% | +16.1% |
| Q4 2019 | $27,857,000 | +39.2% | 20,506,000 | +17.8% | 0.09% | +36.8% |
| Q3 2019 | $20,016,000 | +105.0% | 17,414,000 | +84.5% | 0.07% | +112.5% |
| Q2 2019 | $9,766,000 | +248.4% | 9,440,000 | +267.3% | 0.03% | +300.0% |
| Q2 2018 | $2,803,000 | -84.3% | 2,570,000 | -82.7% | 0.01% | -84.6% |
| Q3 2017 | $17,813,000 | +1.9% | 14,883,000 | +3.4% | 0.05% | 0.0% |
| Q1 2017 | $17,480,000 | -20.6% | 14,387,000 | -14.6% | 0.05% | -22.4% |
| Q3 2016 | $22,012,000 | +74.0% | 16,843,000 | +40.4% | 0.07% | +67.5% |
| Q2 2016 | $12,652,000 | – | 12,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 115,776,000 | $168,437,000 | 3.54% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,004,000 | $4,536,000 | 0.11% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,416,000 | $9,226,000 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 8,908,000 | $12,978,000 | 0.02% |
| Citadel Advisors | 29,066,000 | $42,190,000 | 0.01% |
| BNP PARIBAS FINANCIAL MARKETS | 3,200,000 | $4,614,176,000 | 0.01% |
| PUTNAM INVESTMENTS LLC | 919,000 | $1,341,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 6,681,000 | $9,762,000 | 0.00% |
| CREDIT SUISSE AG/ | 859,000 | $1,239,000 | 0.00% |
| MORGAN STANLEY | 470,000 | $680,000 | 0.00% |